RhumbLine Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-334,270
Closed -$17.5M 3080
2020
Q3
$17.5M Sell
334,270
-32,180
-9% -$1.69M 0.03% 526
2020
Q2
$12.2M Buy
366,450
+1,718
+0.5% +$57.2K 0.02% 672
2020
Q1
$9.92M Buy
364,732
+25,392
+7% +$691K 0.02% 669
2019
Q4
$6.7M Buy
339,340
+42,580
+14% +$840K 0.01% 1078
2019
Q3
$3.85M Buy
296,760
+6,065
+2% +$78.6K 0.01% 1336
2019
Q2
$3.62M Buy
290,695
+14,548
+5% +$181K 0.01% 1381
2019
Q1
$4.01M Buy
276,147
+29,032
+12% +$422K 0.01% 1305
2018
Q4
$2.73M Buy
247,115
+65,839
+36% +$727K 0.01% 1461
2018
Q3
$4.77M Sell
181,276
-4,681
-3% -$123K 0.01% 1139
2018
Q2
$3.8M Buy
185,957
+2,913
+2% +$59.6K 0.01% 1285
2018
Q1
$3.32M Buy
183,044
+7,842
+4% +$142K 0.01% 1299
2017
Q4
$2.44M Buy
175,202
+24,862
+17% +$347K 0.01% 1511
2017
Q3
$2.78M Buy
150,340
+10,125
+7% +$187K 0.01% 1399
2017
Q2
$2.37M Buy
140,215
+11,128
+9% +$188K 0.01% 1473
2017
Q1
$1.72M Buy
129,087
+37,076
+40% +$495K ﹤0.01% 1641
2016
Q4
$1.39M Sell
92,011
-5,371
-6% -$80.8K ﹤0.01% 1653
2016
Q3
$1.14M Buy
97,382
+2,710
+3% +$31.7K ﹤0.01% 1739
2016
Q2
$1.02M Buy
94,672
+17,864
+23% +$193K ﹤0.01% 1770
2016
Q1
$710K Buy
76,808
+1,170
+2% +$10.8K ﹤0.01% 1996
2015
Q4
$1.12M Buy
75,638
+6,835
+10% +$101K ﹤0.01% 1736
2015
Q3
$1.13M Buy
68,803
+2,630
+4% +$43.2K ﹤0.01% 1694
2015
Q2
$1.51M Buy
66,173
+9,495
+17% +$217K ﹤0.01% 1607
2015
Q1
$862K Buy
56,678
+6,225
+12% +$94.7K ﹤0.01% 1953
2014
Q4
$607K Sell
50,453
-1,025
-2% -$12.3K ﹤0.01% 2162
2014
Q3
$584K Sell
51,478
-50
-0.1% -$567 ﹤0.01% 2111
2014
Q2
$622K Sell
51,528
-3,908
-7% -$47.2K ﹤0.01% 2133
2014
Q1
$646K Sell
55,436
-1,900
-3% -$22.1K ﹤0.01% 2054
2013
Q4
$1.01M Sell
57,336
-1,280
-2% -$22.6K ﹤0.01% 1803
2013
Q3
$843K Sell
58,616
-654
-1% -$9.41K ﹤0.01% 1888
2013
Q2
$893K Buy
+59,270
New +$893K ﹤0.01% 1839